Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J M Maris

Showing results (41-50 of 55) with videos related to

Pageof 6
Sort By:
Oncogene|September 22, 1999
Allelic deletion at 11q23 is common in MYCN single copy neuroblastomasC Guo, P S White, M J Weiss, et al.
Medical and Pediatric Oncology|December 7, 2000
Localization of a hereditary neuroblastoma predisposition gene to 16p12-p13M J Weiss, C Guo, S Shusterman, et al.
Medical and Pediatric Oncology|July 24, 2001
Comprehensive analysis of chromosome 1p deletions in neuroblastomaJ M Maris, C Guo, D Blake, et al.
Cancer Research|August 1, 1996
Familial predisposition to neuroblastoma does not map to chromosome band 1p36J M Maris, S M Kyemba, T R Rebbeck, et al.
British Journal of Cancer|April 30, 2009
International consensus for neuroblastoma molecular diagnostics: report from the International Neuroblastoma Risk Group (INRG) Biology CommitteeP F Ambros, I M Ambros, G M Brodeur, et al.
Medical and Pediatric Oncology|July 24, 2001
Biological aspects of neuroblastomas identified by mass screening in QuebecG M Brodeur, A T Look, H Shimada, et al.
Medical and Pediatric Oncology|July 24, 2001
Loss of heterozygosity for chromosome 14q in neuroblastomaP M Thompson, B A Seifried, S K Kyemba, et al.
Clinical Pharmacology and Therapeutics|February 20, 2014
Integrating cell-based and clinical genome-wide studies to identify genetic variants contributing to treatment failure in neuroblastoma patientsN Pinto, E R Gamazon, N Antao, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 28, 2000
Loss of heterozygosity at 1p36 independently predicts for disease progression but not decreased overall survival probability in neuroblastoma patients: a Children's Cancer Group studyJ M Maris, M J Weiss, C Guo, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 6, 1995
A region of consistent deletion in neuroblastoma maps within human chromosome 1p36.2-36.3P S White, J M Maris, C Beltinger, et al.
Pageof 6

Showing results (41-50 of 55) with videos related to

Sort By:
Pageof 6
Oncogene|September 22, 1999
Allelic deletion at 11q23 is common in MYCN single copy neuroblastomasC Guo, P S White, M J Weiss, et al.
Medical and Pediatric Oncology|December 7, 2000
Localization of a hereditary neuroblastoma predisposition gene to 16p12-p13M J Weiss, C Guo, S Shusterman, et al.
Medical and Pediatric Oncology|July 24, 2001
Comprehensive analysis of chromosome 1p deletions in neuroblastomaJ M Maris, C Guo, D Blake, et al.
Cancer Research|August 1, 1996
Familial predisposition to neuroblastoma does not map to chromosome band 1p36J M Maris, S M Kyemba, T R Rebbeck, et al.
British Journal of Cancer|April 30, 2009
International consensus for neuroblastoma molecular diagnostics: report from the International Neuroblastoma Risk Group (INRG) Biology CommitteeP F Ambros, I M Ambros, G M Brodeur, et al.
Medical and Pediatric Oncology|July 24, 2001
Biological aspects of neuroblastomas identified by mass screening in QuebecG M Brodeur, A T Look, H Shimada, et al.
Medical and Pediatric Oncology|July 24, 2001
Loss of heterozygosity for chromosome 14q in neuroblastomaP M Thompson, B A Seifried, S K Kyemba, et al.
Clinical Pharmacology and Therapeutics|February 20, 2014
Integrating cell-based and clinical genome-wide studies to identify genetic variants contributing to treatment failure in neuroblastoma patientsN Pinto, E R Gamazon, N Antao, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 28, 2000
Loss of heterozygosity at 1p36 independently predicts for disease progression but not decreased overall survival probability in neuroblastoma patients: a Children's Cancer Group studyJ M Maris, M J Weiss, C Guo, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 6, 1995
A region of consistent deletion in neuroblastoma maps within human chromosome 1p36.2-36.3P S White, J M Maris, C Beltinger, et al.
Pageof 6